An Open-label Extension Trial to Determine Tolerability and Efficacy of Long-term Oral SPM 927 as Adjunctive Therapy in Patients With Partial Seizures
An Open-label Extension Trial to Determine Tolerability and Efficacy of Long-term Oral SPM 927 as Adjunctive Therapy in Patients With Partial Seizures
The purpose of this trial is to determine whether lacosamide is safe and effective for long-term use in patients with partial-seizures from epilepsy.
Inclusion Criteria:
Exclusion Criteria:
Kehl Kork, Germany
Schwalmstedt-Treysa, Germany
Bern/Biel, Switzerland
Bucks/London, United Kingdom